Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EHMT2 | Q96KQ7 | 6/20 | 0.48 |
| ▸ | EHMT1 | Q9H9B1 | 6/20 | 0.48 |
| ▸ | NCF1 | P14598 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | CASP1 | P29466 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | CHKA | P35790 | 1/20 | 0.40 |
| ▸ | IRAK4 | Q9NWZ3 | 3/20 | 0.39 |
| ▸ | BRD4 | O60885 | 2/20 | 0.36 |
| ▸ | F10 | P00742 | 2/20 | 0.36 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5033237 | 0.99 | EHMT2 (0.48) | EHMT2EHMT1NCF1PKMALOX15 | |
| SCHEMBL5035797 | 0.88 | EHMT2 (0.53) | EHMT2EHMT1NCF1PKMALOX15 | |
| Hydrochloric Acid SCHEMBL5035774 | 0.87 | EHMT2 (0.52) | EHMT2EHMT1NCF1PKMALOX15 | |
| SCHEMBL6377309 | 0.86 | EHMT2 (0.61) | EHMT2EHMT1NCF1PKMALOX15 | |
| Hydrochloric Acid SCHEMBL5037470 | 0.85 | EHMT2 (0.60) | EHMT2EHMT1NCF1PKMALOX15 | |
| SCHEMBL5035782 | 0.83 | EHMT2 (0.48) | EHMT2EHMT1NCF1PKMALOX15 | |
| SCHEMBL5033329 | 0.81 | EHMT2 (0.44) | EHMT2EHMT1NCF1PKMALOX15 | |
| SCHEMBL5036289 | 0.79 | PKM (0.47) | EHMT2EHMT1NCF1PKMALOX15 | |
| SCHEMBL30446792 | 0.71 | NCF1 (0.65) | EHMT2EHMT1NCF1 | |
| SCHEMBL31457629 | 0.69 | NCF1 (0.75) | EHMT2EHMT1NCF1PKMALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1395564-B1 | QUINOLINE DERIVATIVES AS LIGANDS FOR THE NEUROPEPTIDE Y RECEPTOR | HOFFMANN LA ROCHE (CH) | 2008-02-27 | — | — | EP | disclosed |
| US-20050049413-A1 | Quinoline derivatives | MUELLER WERNER (CH) | 2005-03-03 | — | — | US | disclosed |
| US-6818767-B2 | NEUROPEPTIDE Y (NPY) ANTAGONISTS FOR THE TREATMENT OR PREVENTION OF ARTHRITIS, CARDIOVASCULAR DISEASES, DIABETES, RENAL FAILURE, EATING DISORDERS, OR OBESITY | HOFFMANN-LA ROCHE INC. | 2004-11-16 | — | — | US | disclosed |
| US-20020198194-A1 | Quinoline derivatives | HOFFMANN-LA ROCHE INC. | 2002-12-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020198194-A1 | Quinoline derivatives | NPY2R, NPY1R, NPY4R | EHMT2 4668/4885EHMT1 4759/4885NCF1 1052/4885 |
| US-20050049413-A1 | Quinoline derivatives | NPY2R, NPY1R, NPY4R | EHMT2 4668/4885EHMT1 4759/4885NCF1 1052/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.